Hepatic attenuation on CT
Updates to Article Attributes
Body
was changed:
Hepatic attenuation on CT (reflected by Hounsfield values) depends on a combination of factors including the presence or absence (as well as phase) of IV contrast administration.
Allowing for all these factors, the mean unenhanced attenuation value is around 55 HU 4.
Several intrinsic liver pathologies can be attributed a diffuse change in liver attenuation with a amount of hepatic fat being the most prevalent.
Causes of diffusely increased attenuation
- deposition of certain metals
- iron in haemochromatosis and haemosiderosis
- copper in Wilson disease
- glycogen storage disease(es)
- medications/drugs
-
amiodarone hepatotoxicity
- long: long-term amiodarone administration 7-8 - Gold therapy 6
-
amiodarone hepatotoxicity
- previous Thorotrast administration
Causes of diffusely decreased attenuation
- diffuse fatty infiltration (diffuse hepatic steatosis)
- diffuse malignant infiltration
- diffuse non malignant infiltrative disease (e.g. hepatic amyloidosis)
-<a href="/articles/amiodarone-hepatotoxicity">amiodarone hepatotoxicity</a> - long-term amiodarone administration <sup>7-8</sup>- +<a href="/articles/amiodarone-hepatotoxicity">amiodarone hepatotoxicity</a>: long-term amiodarone administration <sup>7-8</sup>